期刊文献+

对暴发性1型糖尿病临床特征的探讨

Clinical Characteristics of Fulminant Type 1 Diabetes Mellitus
下载PDF
导出
摘要 目的对2010年1月至2019年7月发表的暴发性1型糖尿病(FT1DM)个案共81篇116例患者临床特征进行分析和探讨。方法回顾性分析116例患者的临床资料,总结其临床特点。结果男女发病比例为1∶1.17,女性患者发病更早[(31.20±11.24)岁vs(36.93±15.24)岁],均于1周内出现DKA。部分患者伴有前驱感染症状、消化系统症状及三多一少症状。女性患者发病时血糖较低[(34.40±9.75)mmol/L vs(38.77±13.54)mmol/L],HbA1c水平4.6%~8.6%,且女性患者空腹C肽水平更低[(0.03±0.06)mmol/L vs(0.06±0.09)ng/mL],胰岛功能几乎完全丧失。少部分患者T1DM自身抗体阳性。多数患者使用胰岛素强化替代治疗。结论FT1DM病情危重,进展迅速,需长期使用外源性胰岛素替代治疗,应引起高度重视。 Objective To analyse and explore clinical characteristics of 116 patients with fulminant type 1 diabetes mellitus(FT1DM)published from January 2010 to July 2019.Methods The chinical data of 116 patients were analyzed retrospectively,and the clinical features were summarized.Results The incidence ratio of male to female was 1:1.17,and women get sick earlier[(31.20±11.24)vs.(36.93±15.24)years old].All patients presented with ketoacidosis within one week.Some patients had prodromal infection symptoms,digestive system symptoms or diabetes symptoms.Women suffer from lower blood sugar levels than men[(34.40±9.75)vs.(38.77±13.54)mmol/L].The range of HbA1c level was 4.6%-8.6%.Women suffer from lower fasting c-peptide levels than men[(0.03±0.06)vs.(0.06±0.09)ng/mL].Pancreatic beta cells were rapidly destroyed.Some patients’T1DM autoantibody were positive.Most patients need long-term insulin replacement therapy.Conclusion FT1DM has remarkably abrupt onset and lifelong injection of exogenous insulin is inevitable.Physicians should sharpen their awareness of FT1DM.
作者 刘燕晶 张帆 LIU Yan-jing;ZHANG Fan(Department of Endocrinology,Peking University Shenzhen Hospital,Shenzhen 518000,Guangdong Province,China)
出处 《罕少疾病杂志》 2022年第1期89-92,共4页 Journal of Rare and Uncommon Diseases
关键词 1型糖尿病 暴发性 临床特征 Type 1Diabetes Mellitus Fulminant Clinical Characteristics
  • 相关文献

参考文献15

二级参考文献53

  • 1周健,包玉倩,李鸣,刘芳,陈海冰,韩峻峰,陆蔚,马晓静,胡承,项坤三,贾伟平.暴发性1型糖尿病的临床特征及治疗策略探讨[J].中华糖尿病杂志,2009,1(1). 被引量:31
  • 2张弛,周智广,张冬梅,杨晓琳,周敏,林健,黄干,王建平.急骤起病伴胰酶增高的1型糖尿病临床和免疫学特征[J].中华医学杂志,2005,85(14):967-971. 被引量:46
  • 3Imagawa A, Hanafusa T, Miyagawa J, et al. A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an absence of diabetes-related ant/bodies, osaka IDDM study group. N Engl J Med ,2000,342:301-307.
  • 4Shimada A, Morimoto J, Kodama K, et al. T-cell-mediated autoimmunity may be involved in fulminant type 1 diabetes. Diabetes Care ,2002,25:635-636.
  • 5Hanafusa T, Imagawa A. Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners. Nat Clin Pract Endocrinol Metab,2007 ,3 :3645.
  • 6Wang JP, Zhou ZG, Lin J, et al. Islet autoantibodies are associated with HLA-DQ genotypes in Han Chinese patients with type 1 diabetes and their relatives. Tissue Antigens,2007,70:369-375.
  • 7Wenzlau JM, Juhl K, Yu L, et al. The cation efflux transporter ZnT8 (Slc30A8) is a major autoantigen in human type 1 diabetes. Proc Natl Acad Sci U S A,2007,104:17040-17045.
  • 8Iwaoka T. A case of fulminant type 1 diabetes with transiently positive anti-GAD antibodies. Endocr J,2003,50:225-231.
  • 9Sue M,Yoshihara A, Otani T, et al. Characteristics of fulminant type 1 diabetes mellitus. Med Sci Monit,2008,14 : CS97-101.
  • 10Sachdeva N, Asthana D. Cytokine quantitation : technologies and applications. Front Biosci ,2007 ,12 :4682-4695.

共引文献130

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部